. . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . "NCT02921256" . . . . . . "Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer"@en . . . . . . . . . . . . . . . . . "ensayu cl\u00EDnicu"@ast . "klinisch onderzoek"@nl . . . . "2016-10-12T00:00:00Z"^^ . . "2019-04-30T00:00:00Z"^^ . . . . "18"^^ . . . . . . . . . "348"^^ . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer"@en . "Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer"@en . . . . . . . . . . . . . . . . . . . . . . "A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer"@en . . . . . . . . . . . . . . . . . . "clinical trial"@en . . . . . . . . . . .